Solvay Shareholder Denies Takeover Approach

Solvac (Brussels), the family owned holding vehicle that controls a 30.07% stake in Solvay, has denied a Financial Times report that it has been approached by Sanofi-Aventis about a potential sale of the stake. “Solvac denies any contact with third parties about the sale of its participation in Solvay, in part or in total,” Solvac says. The report says Sanofi-Aventis made a direct offer to Solvac that valued the whole of Solvay at €7.2 billion ($9.6 billion), or €85/share. Solvac rejected the bid and believes that Solvay is worth at least...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers